Transmissible spongiform encephalopathies (TSEs) are a family of rare, slow
ly progressive, and universally fatal neurodegenerative syndromes affecting
animals and humans. Until recently, TSEs were of little interest to pediat
ricians. However, since the outbreak in adolescents and the association of
TSEs with new-variant Creutzfeldt-Jakob disease (nvCJD), interest among ped
iatricians and the general public has increased. Even before bovine spongif
orm encephalopathy and nvCJD were linked, the recognition that iatrogenic C
reutzfeldt-Jakob disease (CJD) had been acquired from administration of cad
averic human growth and gonadotropic hormones and from corneal and dura mat
er transplants prompted medical vigilance. Furthermore, recent concern abou
t the potential for transmission of CJD by blood and blood products has rai
sed awareness among public health and regulatory agencies, pediatricians, a
nd the public, although no epidemiologic data support this concern. Because
of worldwide concern (although no cases have been reported in North Americ
a), this review focuses on the potential impact of TSEs, particularly CJD a
nd nvCJD, on the pediatric population.